Donor organ's lymphoma underscores rare risk

A 66 year old man who underwent a kidney transplant last year has already had the kidney removed because it was discovered that lymphoma was present in the organ. Fortunately for the patient, he has not developed lymphoma.

According to NewsObserver.com, the donor was a car accident victim whose organs were harvested at Duke University Medical Center. The Observer also cites statistics from the US Department of Health and Human Services that over the last 15 years, 39 deceased kidney donors in the US had some history of either lymphoma or leukemia.

It is very rare that a person develop cancer after receiving a donated organ, but not unheard of; the United Network for Organ Sharing examined 230,000 organ donations and found 64 such cases.

Every effort is made to make sure that donated organs are safe for those receiving them, but not everything can be caught, especially since time is of the essence in organ donation.

By Ross Bonander

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap